Skip to main content

Table 1 Baseline characteristics of patients (full analysis set)

From: Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs

Variable Esomeprazole 20 mg once daily (n=130)
Women 95 (73.1)
Age  
  Mean±SD (range), years 62.1±12.6 (32–84)
  ≤64 years 63 (48.5)
  ≥65 to ≤74 years 43 (33.1)
  ≥75 years 24 (18.5)
Type of arthritic disease  
  Rheumatoid arthritis 42 (32.3)
  Osteoarthritis 34 (26.2)
  Other chronic condition 54 (41.5)
Duration of disease, mean±SD (range), years 6.0±6.9 (0–38)
Helicobacter pylori infection (serology test) 57 (43.8)
Use of corticosteroids 32 (24.6)
CYP2C19 genotype  
  Poor metaboliser 22 (16.9)
  Hetero extensive metaboliser 68 (52.3)
  Homo extensive metaboliser 40 (30.8)
  1. Values are presented as number of patients (%), unless otherwise stated.
  2. Abbreviation: CYP2C19, cytochrome P450 2C19.